Statement of Changes in Beneficial Ownership (4)
August 09 2019 - 3:42PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Camber Capital Management LP
|
2. Issuer Name
and
Ticker or Trading Symbol
AMAG PHARMACEUTICALS, INC.
[
AMAG
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
__
X
__ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
101 HUNTINGTON AVENUE, SUITE 2101
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
8/7/2019
|
(Street)
BOSTON, MA 02199
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
8/7/2019
|
8/7/2019
|
P
|
|
301000
|
A
|
$7.7857
|
4306000
|
I
|
See Footnotes
(1)
(2)
|
Common Stock
|
8/7/2019
|
8/7/2019
|
P
|
|
50000
|
A
|
$7.74
|
4356000
|
I
|
See Footnotes
(1)
(3)
|
Common Stock
|
8/7/2019
|
8/7/2019
|
P
|
|
4000
|
A
|
$7.575
|
4360000
|
I
|
See Footnotes
(1)
(4)
|
Common Stock
|
8/9/2019
|
8/9/2019
|
P
|
|
26600
|
A
|
$8.9395
|
4386600
|
I
|
See Footnotes
(1)
(5)
|
Common Stock
|
8/9/2019
|
8/9/2019
|
P
|
|
3400
|
A
|
$9.1781
|
4390000
|
I
|
See Footnotes
(1)
(6)
(7)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(1)
|
Securities reported herein for Camber Capital Management LP (the "LP" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund") and another private investment fund (the "Fund") for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein.
|
(2)
|
Of the securities reported for this transaction, 299,074 shares of Common Stock were purchased for the account of the Master Fund and 1,926 shares of Common Stock were purchased for the account of the Fund
|
(3)
|
Of the securities reported for this transaction, 49,680 shares of Common Stock were purchased for the account of the Master Fund and 320 shares of Common Stock were purchased for the account of the Fund
|
(4)
|
Of the securities reported for this transaction, 3,974 shares of Common Stock were purchased for the account of the Master Fund and 26 shares of Common Stock were purchased for the account of the Fund
|
(5)
|
Of the securities reported for this transaction, 26,430 shares of Common Stock were purchased for the account of the Master Fund and 170 shares of Common Stock were purchased for the account of the Fund
|
(6)
|
Of the securities reported for this transaction, 3,378 shares of Common Stock were purchased for the account of the Master Fund and 22 shares of Common Stock were purchased for the account of the Fund
|
(7)
|
As of the closing of trading on August 09, 2019, 4,361,316 shares of Common Stock were held for the account of the Master Fund and 28,684 shares of Common Stock were held for the account of the Fund.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Camber Capital Management LP
101 HUNTINGTON AVENUE
SUITE 2101
BOSTON, MA 02199
|
|
X
|
|
|
Signatures
|
/s/ Stephen DuBois
|
|
8/9/2019
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Mar 2024 to Apr 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Apr 2023 to Apr 2024